The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Breast cancer genetics: What we know and what we need
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
BRCA1 required for transcription-coupled repair of oxidative DNA damage
Gowen, L. C., Avrutskaya, A. V., Latour, A. M., Koller, B. H., & Leadon, S. A. (1998) · Science · doi:10.1126/science.281.5379.1009 · Cited by 496
RetractedA Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Self-citationGenetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301749 · Cited by 3,037
Self-citationThe Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews
Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,281
Liaw, D., Marsh, D. J., Li, J., Dahia, P. L. M., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacoke, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-64 · Cited by 2,091
Risks of cancer in BRCA1-mutation carriers
FORD, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91578-4 · Cited by 1,850
Gene-Expression Profiles in Hereditary Breast Cancer
Hedenfalk, I., Duggan, D., Chen, Y., Radmacher, M., Bittner, M., Simon, R., Meltzer, P., Gusterson, B., Esteller, M., Raffeld, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102223440801 · Cited by 1,733
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
Easton, D. F., Ford, D., & Bishop, D. T. (1995) · PubMed Central · Cited by 1,602
Cancer Risks in BRCA2 Mutation Carriers
Breast Cancer Linkage Consortium, T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1310 · Cited by 1,527
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
Prospects for whole-genome linkage disequilibrium mapping of common disease genes
Kruglyak, L. (1999) · Nature Genetics · doi:10.1038/9642 · Cited by 1,416
Easton, D. F., Bishop, D. T., Ford, D., & Crockford, G. P. (1993) · Europe PMC (PubMed Central) · Cited by 1,243
Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2
Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, D.-S., Regel, E., Dinh, C., Sands, A., Eichele, G., Hasty, P., & Bradley, A. (1997) · Nature · doi:10.1038/386804a0 · Cited by 1,072
Cortez, D., Wang, Y., Qin, J., & Elledge, S. J. (1999) · Science · doi:10.1126/science.286.5442.1162 · Cited by 1,020
Incidence of Cancer in 161 Families Affected by Ataxia–Telangiectasia
Swift, M., Morrell, D., Massey, R. B., & Chase, C. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112263252602 · Cited by 939
Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients With Early-Onset Breast Cancer
Peto, J., Collins, N., Barfoot, R., Seal, S., Warren, W., Rahman, N., Easton, D. F., Evans, C., Deacon, J., & Stratton, M. R. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.11.943 · Cited by 873
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds
Tavtigian, S. V., Simard, J., Rommens, J., Couch, F., Shattuck-Eidens, D., Neuhausen, S., Merajver, S., Thorlacius, S., Offit, K., Stoppa-Lyonnet, D., et al. (1996) · Nature Genetics · doi:10.1038/ng0396-333 · Cited by 839
Self-citationBreast and Other Cancers in Families with Ataxia-Telangiectasia
Swift, M., Reitnauer, P. J., Morrell, D., & Chase, C. L. (1987) · New England Journal of Medicine · doi:10.1056/nejm198705213162101 · Cited by 719
BRCA1 Mutations in Women Attending Clinics That Evaluate the Risk of Breast Cancer
Couch, F. J., DeShano, M. L., Blackwood, M. A., Calzone, K., Stopfer, J., Campeau, L., Ganguly, A., Rebbeck, T., Weber, B. L., Jablon, L., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362002 · Cited by 685
Self-citationIn search of the tumour-suppressor functions of BRCA1 and BRCA2
Scully, R., & Livingston, D. M. (2000) · Nature · doi:10.1038/35044000 · Cited by 643
Involvement of Brca2 in DNA Repair
Patel, K. J., Yu, V. P. C. C., Lee, H., Corcoran, A., Thistlethwaite, F. C., Evans, M. J., Colledge, W. H., Friedman, L. S., Ponder, B. A. J., & Venkitaraman, A. R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80035-0 · Cited by 634
Association of BRCA1 with the hRad50-hMre11-p95 Complex and the DNA Damage Response
Zhong, Q., Chen, C.-F., Li, S., Chen, Y., Wang, C.-C., Xiao, J., Chen, P.-L., Sharp, Z. D., & Lee, W.-H. (1999) · Science · doi:10.1126/science.285.5428.747 · Cited by 626
(2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1407 · Cited by 604
Unusual case of Smith‐Lemli‐Opitz syndrome “type II”
Seller, M. J., Russell, J., & Tint, G. S. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320560305 · Cited by 585
hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response
Lee, J.-S., Collins, K. M., Brown, A. L., Lee, C.-H., & Chung, J. H. (2000) · Nature · doi:10.1038/35004614 · Cited by 529
BRCA1 physically associates with p53 and stimulates its transcriptional activity
Zhang, H., Somasundaram, K., Peng, Y., Tian, H., Zhang, H., Bi, D., Weber, B. L., & El-Deiry, W. S. (1998) · Oncogene · doi:10.1038/sj.onc.1201932 · Cited by 492
Self-citationTranscriptional activation by BRCA1
Chapman, M. S., & Verma, I. M. (1996) · Nature · doi:10.1038/382678a0 · Cited by 436
Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation
Connor, F., Bertwistle, D., Mee, P. J., Ross, G. M., Swift, S., Grigorieva, E., Tybulewicz, V. L. J., & Ashworth, A. (1997) · Nature Genetics · doi:10.1038/ng1297-423 · Cited by 432
Splitting the Chromosome: Cutting the Ties That Bind Sister Chromatids
Nasmyth, K., Peters, J.-M., & Uhlmann, F. (2000) · Science · doi:10.1126/science.288.5470.1379 · Cited by 427
Increased Risk for Cancer in Patients with the Peutz-Jeghers Syndrome
Boardman, L. A., Thibodeau, S. N., Schaid, D. J., Lindor, N. M., McDonnell, S. K., Burgart, L. J., Ahlquist, D. A., Podratz, K. C., Pittelkow, M., & Hartmann, L. C. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-11-199806010-00004 · Cited by 421
Warner, E., Foulkes, W., Goodwin, P., Meschino, W., Blondal, J., Paterson, C., Ozcelik, H., Goss, P., Allingham-Hawkins, D., Hamel, N., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.14.1241 · Cited by 390
Tirkkonen, M., Johannsson, O. T., Agnarsson, B. A., Olsson, H. L., Ingvarsson, S., Karhu, R., Tanner, M., Isola, J. J., Barkardottir, R. B., Borg, Å., et al. (1997) · PubMed · Cited by 354
Heterozygous ATM mutations do not contribute to early onset of breast cancer
FitzGerald, M. G., Bean, J. M., Hegde, S. R., Unsal, H., MacDonald, D. J., Harkin, D. P., Finkelstein, D. M., Isselbacher, K. J., & Haber, D. A. (1997) · Nature Genetics · doi:10.1038/ng0397-307 · Cited by 340
Mortality and Cancer Incidence in 263 Patients With Ataxia-Telangiectasia 2
(1986) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/77.1.89 · Cited by 305
High constant incidence in twins and other relatives of women with breast cancer
Peto, J., & Mack, T. M. (2000) · Nature Genetics · doi:10.1038/82533 · Cited by 301
An Association between the Risk of Cancer and Mutations in the HRAS1 Minisatellite Locus
Krontiris, T. G., Devlin, B., Karp, D. D., Robert, N. J., & Risch, N. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308193290801 · Cited by 287
BRCA1 MUTATIONS IN WOMEN ATTENDING CLINICS THAT EVALUATE THE RISK OF BREAST CANCER
Ouch, F. E. J. C., Hano, M. I. L. D. E. S., Nne, M. A. A., Athleen, K., Topfer, J. I. S., Ampeau, L. I. C., Ebbeck, T. I. R., & Eber, A. L. W. (1997) · Cited by 256
Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat.
Rebbeck, T. R., Kantoff, P. W., Krithivas, K., Neuhausen, S., Blackwood, M. A., Godwin, A. K., Daly, M. B., Narod, S. A., Garber, J. E., Lynch, H. T., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302366 · Cited by 252
Self-citationWooster, R., Mangion, J., Eeles, R., Smith, S., Dowsett, M., Averill, D., Barrett-Lee, P., Easton, D. F., Ponder, B. A. J., & Stratton, M. R. (1992) · Nature Genetics · doi:10.1038/ng1092-132 · Cited by 250
ATM-Heterozygous Germline Mutations Contribute to Breast Cancer–Susceptibility
Broeks, A., Urbanus, J. H. M., Floore, A. N., Dahler, E. C., Klijn, J. G. M., Rutgers, E. J. T., Devilee, P., Russell, N. S., van Leeuwen, F. E., & van't Veer, L. J. (2000) · The American Journal of Human Genetics · doi:10.1086/302746 · Cited by 240
Lakhani, S. R., Gusterson, B. A., Jacquemier, J. D., Sloane, J. P., Anderson, T. J., van de Vijver, M. J., Venter, D. J., Freeman, A., Antoniou, A., McGuffog, L., et al. (2000) · PubMed · Cited by 222
Fodor, F. H., Weston, A., Bleiweiss, I. J., McCurdy, L. D., Walsh, M. M., Tartter, P. I., Brower, S. T., & Eng, C. M. (1998) · The American Journal of Human Genetics · doi:10.1086/301903 · Cited by 220
BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway.
Chen, J. J., Silver, D. P., Cantor, S., Livingston, D. M., & Scully, R. (1999) · PubMed · Cited by 217
Phelan, C. M., Rebbeck, T. R., Weber, B. L., Devilee, P., Ruttledge, M. H., Lynch, H. T., Lenoir, G. M., Stratton, M. R., Easton, D. F., Ponder, B. A. J., et al. (1996) · Nature Genetics · doi:10.1038/ng0396-309 · Cited by 201
Self-citationKainu, T., Juo, S.-H. H., Desper, R., Schäffer, A. A., Gillanders, E., Rozenblum, E., Freas-Lutz, D., Weaver, D., Stephan, D., Bailey-Wilson, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9603 · Cited by 186
Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor.
Park, J. M., Irvine, R. A., Buchanan, G., Koh, S. S., Park, J. M., Tilley, W. D., Stallcup, M. R., Press, M. F., & Coetzee, G. A. (2000) · PubMed · Cited by 168
Prophylactic Surgery in Women With a Hereditary Predisposition to Breast and Ovarian Cancer
Eisen, A. F., Rebbeck, T. R., Wood, W. C., & Weber, B. L. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.9.1980 · Cited by 140
Self-citationAndrogen receptor gene mutation in male breast cancer.
Lobaccaro, J.-M., Lumbroso, S., Belon, C., Galtier-Dereure, F., Bringer, J., Lesimple, T., Namer, M., Cutull, B. F., Pujol, H., & Sultan, C. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.11.1799 · Cited by 135 · cited 1×
“Two germline mutations in the androgen receptor gene have been reported as susceptibility alleles for male breast cancer, both in the zinc finger and both in families with clinical evidence of androgen insensitivity, but analysis of larger series has not identified additional mutations, indicating that this is a rare…”
ATM mutations in cancer families.
Vořechovský, I., Luo, L., Lindblom, A., Negrini, M., WEBSTER, A. D. B., Croce, C. M., & Hammarström, L. L. G. (1996) · PubMed · Cited by 134
Thymic lymphomas in mice with a truncating mutation in Brca2.
Friedman, L. S., Thistlethwaite, F. C., Patel, K., Yu, V. P. C. C., Lee, H., Venkitaraman, A. R., Abel, K., Carlton, M. B. L., Hunter, S. M., Colledge, W. H., et al. (1998) · PubMed · Cited by 130
Effect of BRCA1 and BRCA2 on the Association Between Breast Cancer Risk and Family History
Claus, E. B., Schildkraut, J. M., Iversen, E. S., Berry, D. A., & Parmigiani, G. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.23.1824 · Cited by 130
The role of ataxia-telangiectasia heterozygotes in familial breast cancer.
Chen, J., Birkholtz, G. G., Lindblom, P., Rubio‐Terres, C., & Lindblom, A. (1998) · PubMed · Cited by 118
Janin, N., Andrieu, N., Ossian, K., Laugé, A., Croquette, M.-F., Griscelli, C., Debré, M., Paillerets, B. B., Aurias, A., & Stoppa‐Lyonnet, D. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690460 · Cited by 109
Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia
Inskip, H. M., Kinlen, L. J., Taylor, A. M. R., Woods, C. G., & Arlett, C. F. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690209 · Cited by 103
Izatt, L., Greenman, J., Hodgson, S., Ellis, D., Watts, S., Scott, G., Jacobs, C., Liebmann, R. D., Zvelebil, M., Mathew, C. G., et al. (1999) · Genes Chromosomes and Cancer · Cited by 96
A BRCA1 mutant alters G2-M cell cycle control in human mammary epithelial cells.
Larson, J. S., Tonkinson, J. L., & Lai, M.-T. (1997) · PubMed · Cited by 82
Tainu, T. (2000) · Medical Entomology and Zoology · Cited by 74
Izatt, L., Greenman, J., Hodgson, S., Ellis, D., Watts, S., Scott, G., Jacobs, C., Liebmann, R. D., Zvelebil, M., Mathew, C. G., et al. (1999) · Genes Chromosomes and Cancer · Cited by 71
BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers.
Shih, H. A., Nathanson, K. L., Seal, S., Collins, N., Stratton, M. R., Rebbeck, T. R., & Weber, B. L. (2000) · PubMed · Cited by 69
Self-citationThe genetic epidemiology of BRCA1
Easton, D., Narod, S., Ford, D., & Steel, M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92256-x · Cited by 66
Screening breast cancer patients for Norwegian ATM mutations
Laake, K., Vu, P., Andersen, T. I., Erikstein, B., Kåresen, R., Lønning, P. E., Skovlund, E., & Børresen‐Dale, A. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1519 · Cited by 11
Cited by
Cancer Susceptibility and the Functions of BRCA1 and BRCA2
Venkitaraman, A. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00615-3 · Cited by 1,713
Gelmon, K. A., Tischkowitz, M., Mackay, H., Swenerton, K., Robidoux, A., Tonkin, K., Hirte, H., Huntsman, D., Clemons, M., Gilks, B., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70214-5 · Cited by 1,117
BRCA2 Function in DNA Binding and Recombination from a BRCA2-DSS1-ssDNA Structure
Yang, H., Jeffrey, P. D., Miller, J., Kinnucan, E., Sun, Y., Thomä, N. H., Zheng, N., Chen, P.-L., Lee, W.-H., & Pavletich, N. P. (2002) · Science · doi:10.1126/science.297.5588.1837 · Cited by 705
Insights into DNA recombination from the structure of a RAD51–BRCA2 complex
Pellegrini, L., Yu, D. S., Lo, T., Anand, S., Lee, M., Blundell, T. L., & Venkitaraman, A. R. (2002) · Nature · doi:10.1038/nature01230 · Cited by 704
Guttmacher, A. E., & Collins, F. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmra012240 · Cited by 629
Metadata
- Authors
- Nathanson, K. N., Wooster, R., & Weber, B. L.
- Venue
- Nature Medicine
- Published
- 2001-05
- Volume
- 7
- Issue
- 5
- Pages
- 552-556
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1595797072
- Cited by
- 466
- References
- 63
- FWCI
- 16.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.